Schedule 13G ownership disclosure
REVIVA PHARMACEUTCLS HLDGS I
Common Stock, par value $0.0001 per share · CUSIP: 76152G100
Event date: 2025-06-30
- Filing-level shares
- 8,000,000.00
- Percent of class
- 9.9%
- HIGHBRIDGE CAPITAL MANAGEMENT, LLC
Shares: 8,000,000.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-003637
- Form type
- SCHEDULE 13G
- Filer
- HIGHBRIDGE CAPITAL MANAGEMENT LLC
- CIK
- CIK 919185
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership